Avista Healthcare

XHANCE uses Optinose® Exhalation Delivery System to uniquely deposit a proven steroid in areas of inflammation deep in the nose FDA approval based on five clinical trials evaluating over 1,500 adult patients Availability in the U.S. expected in the second quarter 2018 Yardley, PA, Sept. 18, 2017 – (Business Wire) – Optinose, an ENT / […]

Stockholm, June 28th 2017 – (Business Wire) – Trimb Healthcare AB (“Trimb”) has acquired a portfolio of well-established European OTC products from Cilag GmbH International and Janssen Pharmaceutica NV (collectively, “J&J”). The products, which include Pevaryl®, Fungoral®, Gyno-Pevaryl® and Epi-Pevaryl®, are based on the anti-fungal substances econazole and ketoconazole and are used to treat common […]

North Billerica, MA, June 14 2017 – (Business Wire) – Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH), today announced an agreement to sell 3,000,000 shares of its common stock to be offered by certain of its existing stockholders (the “Selling Stockholders”), pursuant to an effective shelf registration statement filed with the Securities and Exchange […]

Private equity groups Nordic Capital and Avista Capital Partners raised gross proceeds of 805 million pounds through the sale of British medical technology giant ConvaTec Group Plc (CTEC.L). The investors sold an aggregate of 250 million shares at 322 pence per share, after the size of the placing was increased due to strong investor demand. […]

Rockville, MD and New York, June 5, 2017 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm, and National Spine & Pain Centers, LLC (“NSPC” or “the Company”) announced that Avista has acquired NSPC from Sentinel Capital Partners (“Sentinel”). Founded in 1998 and headquartered in Rockville, Maryland, NSPC is a leading management services […]

Yardley, PA, May 9, 2017 – (Business Wire) – OptiNose, a commercial-stage ENT / Allergy specialty pharmaceutical company, today announced that it has closed a $37 million Series D financing led by Fidelity Management and Research Company with participation from Avista Capital Partners, Entrepreneurs Fund and other current investors. OptiNose will use the additional capital […]

Avantor to Acquire VWR for $33.25 per Common Share In An All Cash Transaction Valued At $6.4 Billion Avantor’s Acquisition of VWR Will Create a Vertically Integrated, Global Player in Manufacturing and Supply Chain Solutions for the Life Sciences, Advanced Technologies, and Research Industries Combined Company Will Provide Broad Offerings and Compelling Solutions for Customers […]

North Billerica, MA, May 5, 2017 – (Business Wire) – Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH), today announced an agreement to sell 3,000,000 shares of its common stock to be offered by certain of its existing stockholders (the “Selling Stockholders”), pursuant to an effective shelf registration statement filed with the Securities and Exchange […]

Albany, NY, April 06, 2017 – (GLOBE NEWSWIRE) — AngioDynamics, Inc. (NASDAQ:ANGO) (the “Company”), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the pricing of the previously announced underwritten public offering by certain of its stockholders (the “Selling Stockholders”) of 2.35 million shares […]

March 28, 2017 – Nordic Capital and Avista (each as defined below) have today agreed the sale of a 19.95% shareholding (the “Sale”) in ConvaTec Group Plc (“ConvaTec”) to Novo A/S, the investment holding company in the Novo group, responsible for the management of the assets of the Novo Nordisk Foundation, a charitable foundation focused […]

North Billerica, MA, March 13, 2017 – (Business Wire) – Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH), today announced an agreement to sell 3,000,000 shares of its common stock to be offered by certain of its existing stockholders (the “Selling Stockholders”), pursuant to an effective shelf registration statement filed with the Securities and Exchange […]

Zurich, February 28, 2017 – Acino signed a deal with certain subsidiaries of Endo International plc to acquire Litha Healthcare in South Africa. Litha Healthcare, headquartered in Midrand, Johannesburg, is a pharma group with around 160 employees providing products and services to public and private hospitals, pharmacies, general and specialist practitioners, as well as government […]